One-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy

BACKGROUND: Central serous chorioretinopathy (CSC) is characterized by an accumulation of subretinal fluid (SRF) in the macula. It is usually treated by laser photocoagulation or photodynamic therapy (PDT) with consisting of different doses and power. This study aimed to compare the efficacy of half...

Descripción completa

Detalles Bibliográficos
Autores principales: Pichai, Jirarattanasopa, Vanchalerm, Banchasakjaroen, Mansing, Ratanasukon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802284/
https://www.ncbi.nlm.nih.gov/pubmed/33430812
http://dx.doi.org/10.1186/s12886-020-01796-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802284/
https://www.ncbi.nlm.nih.gov/pubmed/33430812
http://dx.doi.org/10.1186/s12886-020-01796-0

Ejemplares similares